<DOC>
	<DOC>NCT02869269</DOC>
	<brief_summary>Previous studies have shown that colorectal cancer patients' prognosis and overall survival was related with immune cell expression in patients' tissue. However, the circulating immune cell activity changes in patients' blood has few studies. The purpose of this study is to analyze the variation of circulating immune cell activity in colorectal patients' blood which is classed as clinical staging.</brief_summary>
	<brief_title>A Study of Circulating Immune Cell Activity Changes in Blood of Colorectal Cancer Patients</brief_title>
	<detailed_description>The patients were classed as clinical staging 1. Early (stage1+2) and Late(stage3+4) 2. regional lymph node metastasis 3. Distant metastasis 4. TNM stage</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>patient who was planned to undergo colorectal cancer surgery. age &lt; 20 years old history of hypersensitivity reaction in propofol or sevoflurane history of previous cancer patient with ongoing inflammation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>